naltrexone has been researched along with Complications of Diabetes Mellitus in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| McLaughlin, PJ; Purushothaman, I; Sassani, JW; Zagon, IS | 2 |
| Ljubimov, AV | 1 |
| Brewer, C; de Jong, C; Williams, J | 1 |
| Klocek, MS; McLaughlin, PJ; Sassani, JW; Zagon, IS | 1 |
| Carroll, MA; McLaughlin, PJ; Sassani, JW; Zagon, IS | 1 |
| Hayashi, SS; Kamei, J; Ohsawa, M | 1 |
| Abdelkader, H; Alany, RG; McGhee, CNj; Patel, DV | 1 |
| Immonen, JA; McLaughlin, PJ; Pothering, CA; Zagon, IS | 1 |
| Abdelkader, H; Al-Kassas, R; Alany, RG; Wu, Z | 1 |
| McLaughlin, PJ; Zagon, IS | 1 |
5 review(s) available for naltrexone and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin.
Topics: Animals; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Dry Eye Syndromes; Enkephalins; Humans; Insulin; Naltrexone; Narcotic Antagonists; Receptors, Opioid | 2021 |
Diabetic complications in the cornea.
Topics: Aldehyde Reductase; Animals; Corneal Diseases; Diabetes Complications; Disease Models, Animal; Enzyme Inhibitors; Humans; Insulin; Naltrexone; Wound Healing | 2017 |
Rapid opiate detoxification and antagonist induction under general anaesthesia or intravenous sedation is humane, sometimes essential and should always be an option. Three illustrative case reports involving diabetes and epilepsy and a review of the liter
Topics: Administration, Intravenous; Adult; Anesthesia, General; Bioethical Issues; Diabetes Complications; Epilepsy; Heroin Dependence; Humans; Hypnotics and Sedatives; Male; Naltrexone; Narcotic Antagonists; Remission Induction; Substance Withdrawal Syndrome | 2014 |
Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.
Topics: Analgesics, Opioid; Animals; Corneal Diseases; Diabetes Complications; Disease Models, Animal; Epithelium; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Wound Healing | 2010 |
New therapeutic approaches in the treatment of diabetic keratopathy: a review.
Topics: Animals; Cornea; Corneal Diseases; Diabetes Complications; Epithelium, Corneal; Humans; Insulin; Naltrexone; Nerve Growth Factors; Nicergoline; Trigeminal Ganglion; Wound Healing | 2011 |
6 other study(ies) available for naltrexone and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications.
Topics: Animals; Blood Glucose; Body Weight; Cornea; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Enkephalin, Methionine; Eye; Male; Naltrexone; Rats, Sprague-Dawley; Receptors, Opioid; Severity of Illness Index; Time Factors | 2021 |
Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Corneal Diseases; Diabetes Complications; Disease Models, Animal; Enkephalin, Methionine; Epithelium, Corneal; Intraocular Pressure; Male; Naltrexone; Narcotic Antagonists; Rabbits; Regeneration; Time Factors | 2010 |
Effect of acute topical application of +-pentazocine on the mechanical allodynia in diabetic mice.
Topics: Administration, Topical; Animals; Diabetes Complications; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Naltrexone; Nitric Oxide; Pentazocine; Receptors, Opioid, kappa; Receptors, sigma; Sigma-1 Receptor | 2010 |
Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats.
Topics: Administration, Topical; Animals; Blood Glucose; Diabetes Complications; Diabetes Mellitus, Experimental; DNA; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Skin; Wound Healing | 2011 |
Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects.
Topics: Administration, Ophthalmic; Corneal Diseases; Diabetes Complications; Drug Stability; Light; Lipids; Liposomes; Naltrexone; Narcotic Antagonists; Oxidation-Reduction; Particle Size; Photolysis; Rheology; Viscosity | 2012 |
The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease.
Topics: Animals; Antineoplastic Agents; Autoimmune Diseases; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Diabetes Complications; Enkephalin, Methionine; Epithelium; Homeostasis; Humans; Lymphocytes; Naltrexone; Narcotic Antagonists; Neoplasms; Receptors, Opioid; Wound Healing | 2012 |